Form 4 Filing for Arcutis Biotherapeutics, Inc.

This filing details transactions by Neha Krishnamohan, a director at Arcutis Biotherapeutics, Inc. On June 5, 2026, 5,778 shares of Common Stock were acquired under transaction code "A". Additionally, an option to buy 16,667 shares of Common Stock was granted, with both the RSUs and the option vesting on the earlier of the first anniversary of the grant date or immediately before the next annual stockholder's meeting, subject to continued service. The option has an exercise price of $21.23 and expires on June 5, 2036. Following these transactions, Neha Krishnamohan directly owns 27,901 shares of Common Stock and holds options for 16,667 shares.